These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 10214348)
21. Functional interplay between p53 and E2F through co-activator p300. Lee CW; Sørensen TS; Shikama N; La Thangue NB Oncogene; 1998 May; 16(21):2695-710. PubMed ID: 9652736 [TBL] [Abstract][Full Text] [Related]
22. Activity of the retinoblastoma family proteins, pRB, p107, and p130, during cellular proliferation and differentiation. Sidle A; Palaty C; Dirks P; Wiggan O; Kiess M; Gill RM; Wong AK; Hamel PA Crit Rev Biochem Mol Biol; 1996 Jun; 31(3):237-71. PubMed ID: 8817077 [TBL] [Abstract][Full Text] [Related]
23. A new member of the DP family, DP-3, with distinct protein products suggests a regulatory role for alternative splicing in the cell cycle transcription factor DRTF1/E2F. Ormondroyd E; de la Luna S; La Thangue NB Oncogene; 1995 Oct; 11(8):1437-46. PubMed ID: 7478568 [TBL] [Abstract][Full Text] [Related]
24. The molecular basis of E2F-1/DP-1-induced S-phase entry and apoptosis. Shan B; Farmer AA; Lee WH Cell Growth Differ; 1996 Jun; 7(6):689-97. PubMed ID: 8780882 [TBL] [Abstract][Full Text] [Related]
25. Key roles for E2F1 in signaling p53-dependent apoptosis and in cell division within developing tumors. Pan H; Yin C; Dyson NJ; Harlow E; Yamasaki L; Van Dyke T Mol Cell; 1998 Sep; 2(3):283-92. PubMed ID: 9774967 [TBL] [Abstract][Full Text] [Related]
27. Inhibition of E2F-4/DP-1-stimulated transcription by p202. Choubey D; Gutterman JU Oncogene; 1997 Jul; 15(3):291-301. PubMed ID: 9233764 [TBL] [Abstract][Full Text] [Related]
28. Adenovirus-mediated overexpression of the transcription factor E2F-1 induces apoptosis in human breast and ovarian carcinoma cell lines and does not require p53. Hunt KK; Deng J; Liu TJ; Wilson-Heiner M; Swisher SG; Clayman G; Hung MC Cancer Res; 1997 Nov; 57(21):4722-6. PubMed ID: 9354430 [TBL] [Abstract][Full Text] [Related]
29. Involvement of retinoblastoma (Rb) and E2F transcription factors during photodynamic therapy of human epidermoid carcinoma cells A431. Ahmad N; Gupta S; Mukhtar H Oncogene; 1999 Mar; 18(10):1891-6. PubMed ID: 10086343 [TBL] [Abstract][Full Text] [Related]
30. Deregulated transcription factor E2F-1 expression leads to S-phase entry and p53-mediated apoptosis. Qin XQ; Livingston DM; Kaelin WG; Adams PD Proc Natl Acad Sci U S A; 1994 Nov; 91(23):10918-22. PubMed ID: 7971984 [TBL] [Abstract][Full Text] [Related]
31. Apoptosis induction by E2F-1 via adenoviral-mediated gene transfer results in growth suppression of head and neck squamous cell carcinoma cell lines. Liu TJ; Wang M; Breau RL; Henderson Y; El-Naggar AK; Steck KD; Sicard MW; Clayman GL Cancer Gene Ther; 1999; 6(2):163-71. PubMed ID: 10195883 [TBL] [Abstract][Full Text] [Related]
32. Multiple members of the E2F transcription factor family are the products of oncogenes. Xu G; Livingston DM; Krek W Proc Natl Acad Sci U S A; 1995 Feb; 92(5):1357-61. PubMed ID: 7877982 [TBL] [Abstract][Full Text] [Related]
33. Induction of apoptosis in human esophageal cancer cells by sequential transfer of the wild-type p53 and E2F-1 genes: involvement of p53 accumulation via ARF-mediated MDM2 down-regulation. Itoshima T; Fujiwara T; Waku T; Shao J; Kataoka M; Yarbrough WG; Liu TJ; Roth JA; Tanaka N; Kodama M Clin Cancer Res; 2000 Jul; 6(7):2851-9. PubMed ID: 10914734 [TBL] [Abstract][Full Text] [Related]
34. Overexpression of E2F-1 in glioma triggers apoptosis and suppresses tumor growth in vitro and in vivo. Fueyo J; Gomez-Manzano C; Yung WK; Liu TJ; Alemany R; McDonnell TJ; Shi X; Rao JS; Levin VA; Kyritsis AP Nat Med; 1998 Jun; 4(6):685-90. PubMed ID: 9623977 [TBL] [Abstract][Full Text] [Related]
35. Topoisomerase IIalpha mediates E2F-1-induced chemosensitivity and is a target for p53-mediated transcriptional repression. Nip J; Hiebert SW Cell Biochem Biophys; 2000; 33(2):199-207. PubMed ID: 11325040 [TBL] [Abstract][Full Text] [Related]
36. Alterations in G1/S cell-cycle control contributing to carcinogenesis. Kaelin WG Ann N Y Acad Sci; 1997 Dec; 833():29-33. PubMed ID: 9616737 [TBL] [Abstract][Full Text] [Related]
38. The paradox of E2F1: oncogene and tumor suppressor gene. Johnson DG Mol Carcinog; 2000 Mar; 27(3):151-7. PubMed ID: 10708476 [TBL] [Abstract][Full Text] [Related]
39. Combination E2F-1 and p53 gene transfer does not enhance growth inhibition in human squamous cell carcinoma of the head and neck. Frank DK; Liu TJ; Frederick MJ; Clayman GL Clin Cancer Res; 1998 Sep; 4(9):2265-72. PubMed ID: 9748148 [TBL] [Abstract][Full Text] [Related]
40. Amplification of the E2F1 transcription factor gene in the HEL erythroleukemia cell line. Saito M; Helin K; Valentine MB; Griffith BB; Willman CL; Harlow E; Look AT Genomics; 1995 Jan; 25(1):130-8. PubMed ID: 7774910 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]